Drugs for Lung Cancer Flashcards
When is bevacizumab not recommended?
squamous cell carcinomas because it can lead to severe bleeding and increased cavitation.
Also when there is hemoptysis or brain metastases
What mutations can render erlotinib inneffective?
KRAS mutations because the proliferative pathway remains active downstream of the drug blockade
Which mutations are more common in non-smokers?
EGFR, EML4-ALK, and hMSH2
What is treatment for SCLC?
etoposide and cisplatin or carboplatin. Surgery is typically not an option because of early metastisis
What is treatment for NSCLC?
cisplatin AND paclitaxel, gemcitabine, docetaxel.
If EGFR positive use erlotinb. Bevacizumab for those with non-squamous histo or hemoptysis.
What is MOA of carboplatin?
forms DNA intrastrand crosslinks and adducts
What is MOA of cisplatin?
forms DNA intrastrand crosslinks and adducts
What is MOA of cyclophosphamide?
pro-drug of active alkylating moiety
What is MOA of doxorubicin?
intercalator, free radical generator, topo II inhibitor
What is MOA of etoposide?
DNA topo II complex stabilizer
What is MOA of gemcitabine?
DNA polymerase inhibitor via incorporation of triphosphate form during DNA synthesis
What is MOA of ifosfamide?
intra and inter-strand cross linker
What is MOA of irnotecan?
DNA-topo I complex stabilizer
What is MOA of paclitaxel?
microtubule stabilizer inhibition depolymerization
What is MOA of pemetrexed?
DHFR inhbitor